Avalon Trust’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.7M Buy
35,923
+867
+2% +$471K 1.22% 27
2025
Q4
$20.3M Sell
35,056
-137
-0.4% -$77.5K 1.31% 20
2025
Q3
$17.1M Sell
35,193
-507
-1% -$236K 1.11% 24
2025
Q2
$14.5M Sell
35,700
-1,506
-4% -$630K 1.06% 25
2025
Q1
$18.5M Buy
37,206
+422
+1% +$229K 1.47% 19
2024
Q4
$19.1M Buy
36,784
+2,162
+6% +$1.19M 1.36% 22
2024
Q3
$21.4M Sell
34,622
-274
-0.8% -$162K 1.58% 22
2024
Q2
$19.3M Sell
34,896
-1,251
-3% -$717K 1.53% 21
2024
Q1
$21M Sell
36,147
-150
-0.4% -$84.2K 1.72% 21
2023
Q4
$19.3M Buy
36,297
+495
+1% +$240K 1.76% 21
2023
Q3
$18.1M Sell
35,802
-260
-0.7% -$139K 1.8% 20
2023
Q2
$18.8M Buy
36,062
+2,718
+8% +$1.47M 1.7% 22
2023
Q1
$19.2M Buy
+33,344
New +$18.8M 1.91% 21

Other funds holding TMO

Avalon Trust's TMO Position: Q1 2026 in Review

Avalon Trust increased its Thermo Fisher Scientific (TMO) stake by 2.5% in Q1 2026, buying an estimated $471K and bringing the position to 35,923 shares worth $17.7M. The position accounts for 1.22% of the portfolio, ranked #27.

Avalon Trust first reported a position in TMO in Q1 2023 and has held it in 13 quarters since. The position peaked at $21.4M in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Avalon Trust held 35,923 shares of Thermo Fisher Scientific worth $17.7M as of Q1 2026.
  • Avalon Trust bought 867 Thermo Fisher Scientific shares in Q1 2026, an estimated $471K.
  • Thermo Fisher Scientific made up 1.22% of Avalon Trust's portfolio in Q1 2026, its #27 holding.
  • Avalon Trust first reported a position in Thermo Fisher Scientific in Q1 2023 and has held it in 13 quarters since.
  • Avalon Trust's Thermo Fisher Scientific position peaked at $21.4M in Q3 2024.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Avalon Trust's 13F filing for Q1 2026, filed 6 May 2026.